Skip to main content

Advertisement

Table 5 Procedure related characteristics according to pocket hematoma

From: Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?

Characteristics PH positive group (n = 26) PH negative group (n = 109) P-value
INR at the day of implanta 2.1 (2.0–2.5) 2.0 (1.9–2.5) 0.122
Generator exchange and/or pocket revision, n (%) 3 (11.5) 11 (10.1) 1.0
New implantation, n (%) 19 (73.1) 82 (75.2) 1.0
Upgrade and/or lead revision, n (%) 4 (15.4) 16 (14.7) 1.0
Pacemaker, n (%) 1 (3.8) 23 (21.1) 0.045
ICD, n (%) 25 (96.2) 86 (78.9)  
Number of leads implanted
 One, n (%) 2 (7.7) 24 (22.0) 0.165
 Two, n (%) 8 (30.8) 42 (38.5) 0.610
 Three, n (%) 13 (50.0) 32 (29.4) 0.076
 Submuscular pocket, n (%) 1 (3.8) 4 (3.7) 1.0
Venous route other than subclavian
 Axillary, n (%) 3 (11.5) 9 (8.3) 0.700
 Cephalic, n (%) 2 (7.7) 5 (4.6) 0.620
 Local tranexamic acid use 4 (15.4) 48 (44.0) 0.013
  1. DAPT dual antiplatelet therapy, ICD implantable cardioverter defibrillator, INR international normalized ratio, PH Pocket hematoma. a The median INR level of patients with warfarin continuation strategy